Clinical research questions, answered
Each page answers one question in its first two sentences, then gives the detail, the primary sources and a free way to practice it.
For site staff
- What is an audit in ICH E6(R3), and how is it different from monitoring and inspection? ICH E6(R3) defines an audit as a systematic and independent examination of trial-related activities and records, performed by the sponsor, a service provider such as a CRO, or the institution, to determine whether the trial was run and its data recorded and reported according to the protocol, SOPs, GCP and the applicable regulations (ICH E6(R3) Glossary).
- What is a delegation log in a clinical trial, and who signs it? A delegation log is the site's record of which trial-related tasks the investigator has delegated to which people or parties, and ICH E6(R3) requires the investigator to make sure that record is kept (ICH E6(R3) 2.3.3).
- What is the difference between a protocol deviation and a protocol violation? ICH E6(R3) does not use the word violation: it speaks of protocol deviations and asks the investigator to document all of them, then explain the important ones and prevent their recurrence (ICH E6(R3) 2.5.3).
- What are essential documents in a clinical trial, and what goes in the investigator site file? Essential records are the documents and data, in any format, that let the trial be managed and let anyone evaluate how it was run and whether its results can be trusted; ICH E6(R3) lists them in Appendix C (ICH E6(R3) Glossary).
- What is a source document in a clinical trial, and what does ALCOA+ mean? A source record is the original document or data, or a certified copy of it, in any media: medical records, participant entries such as ePRO, pharmacy and laboratory records, and data from wearables and other instruments (ICH E6(R3) Glossary).
- What is Form FDA 1572, and who needs to sign it? Form FDA 1572 is the Statement of Investigator: before a US drug study under an IND begins at a site, the sponsor must obtain it signed by the investigator (21 CFR 312.53(c)).
- How should site staff run the informed consent process? Informed consent is a process, not a signature: the participant receives clear information, has ample time and the chance to ask questions, decides freely, and only then signs and dates a consent form the IRB or ethics committee has given a favorable opinion to (ICH E6(R3) 2.8.6).
- What does 21 CFR Part 11 mean for clinical research site staff? Part 11 sets the conditions under which FDA treats electronic records and electronic signatures as trustworthy, reliable and equivalent to paper and handwritten signatures, and it applies to electronic records kept under FDA's record requirements (21 CFR 11.1).
- How should a research site prepare for a monitoring visit? Prepare for a monitoring visit by working the open items from the last visit, bringing source records and data entry up to date, and checking the consent forms, safety reports, product records and site file the monitor will review (ICH E6(R3) 3.11.4.5.2).
- What changed in ICH E6(R3)? ICH E6(R3) keeps the core duties of good clinical practice but builds quality into trial design and scales oversight to each trial's risks (ICH E6(R3) Principle 6; ICH E6(R3) Principle 7).
- Where can I get a delegation of authority log template? Download our free delegation of authority log template below, a spreadsheet licensed CC BY 4.0 with one row per person: name, role, delegated tasks, training, start and end dates, initials and the investigator's authorization.
For site leaders and investigators
- When does ICH E6(R3) take effect? ICH adopted the E6(R3) principles and Annex 1 on 6 January 2025, and each regulator then brings it into force on its own timeline (ICH E6(R3), document history).
- What are the investigator's responsibilities under ICH E6(R3)? The investigator is responsible for the conduct of the trial at the site and for the participants in their care: they must be qualified, have the time, staff and facilities the trial needs, follow the protocol, obtain informed consent, provide medical care and report safety events, and keep accurate records (ICH E6(R3) 2.1.1).
- What training records does a clinical research site need? A site needs evidence that every person working on a trial is qualified by education, training and experience for the tasks they were delegated: CVs, licenses, GCP training and training on the current protocol (ICH E6(R3) 2.3.2).
- How should a research site prepare for an FDA inspection? An FDA investigator may ask, at reasonable times, to access, copy and verify the clinical investigator's records, so a site is ready when its records are complete, current and retrievable on the day, not after (21 CFR 312.68).
- What should a clinical trial site readiness checklist include? A site is ready when its investigator and staff are qualified, trained on the protocol and on the delegation record, ethics and regulatory approvals and signed agreements are on file, and the essential records expected before the trial starts are in place (ICH E6(R3) C.2.5).
- How should a site train new clinical research staff? Train new site staff in three layers: Good Clinical Practice for the role, the protocol and their delegated tasks before they do them, and every trial system they will use, recording each step (ICH E6(R3) 2.3.2).
- How do you onboard a new principal investigator? Onboard a new principal investigator by filing evidence of qualifications, training them on the protocol, Investigator's Brochure and product, and confirming they have time, staff and facilities for the trial (ICH E6(R3) 2.2.2).
- How often does GCP training need to be renewed, and how should a site track it? ICH E6(R3) sets no expiry date for GCP training, but NIH policy NOT-OD-16-148 expects staff on NIH-funded clinical trials to refresh it at least every three years, and many sponsors use the same interval.
For sponsors and CROs
- What is risk-based monitoring under ICH E6(R3)? Risk-based monitoring means the sponsor decides how much monitoring a trial needs, and what kind, from the risks that trial actually carries, rather than checking every data point at every site (ICH E6(R3) 3.11.4).
- How do sponsors and CROs select clinical trial sites? The sponsor is responsible for selecting investigators and institutions, and each investigator must be qualified by education, training and experience and show adequate resources and facilities to run the trial properly (ICH E6(R3) 3.7.1).
- What causes clinical trial site activation delays? Site activation is usually delayed by the steps that must be finished before a trial starts: contract and budget agreement, ethics and regulatory approvals, essential records, product supply, and staff who are qualified, trained and delegated (ICH E6(R3) C.2.5).
New to clinical research
- What is the difference between an IRB and an IEC? An Institutional Review Board (IRB) and an Independent Ethics Committee (IEC) are the same thing under ICH E6(R3): an independent body of medical and non-medical members that protects the rights, safety and well-being of trial participants by reviewing the protocol, the investigators, the facilities and the consent materials (ICH E6(R3) Glossary).
- Sponsor, CRO, investigator and site: who does what in a clinical trial? The sponsor takes responsibility for starting, managing and financing the trial; a CRO is a service provider the sponsor or investigator uses for trial tasks; and the investigator leads the trial at a site and is responsible for its conduct and for the participants there (ICH E6(R3) Glossary).
For AI teams
- How do you evaluate an AI model on clinical trial work? Test the model on the decisions the work actually requires, such as consent, eligibility, safety reporting and deviations, scored with a rubric tied to ICH E6(R3), and compare it with practitioners who answered the same items.
- Can AI be used in a clinical trial run under GCP? Yes: ICH E6(R3) does not forbid any technology, but a tool used for trial activities that affect participants or data must meet its rules for computerised systems, including documented procedures, trained users, security and risk-based validation for its intended use (ICH E6(R3) 4.3.4).
- Can AI do clinical research coordinator work? Not the whole job: AI can help draft and check records, but ICH E6(R3) keeps consent and other delegated trial tasks with qualified people overseen by the investigator (ICH E6(R3) 2.3.1).
- What makes a good expert reviewer for AI evaluation in clinical trial operations? A good expert reviewer is a practitioner who does the work being tested, such as a coordinator, monitor or investigator, and rates each item independently against a written rubric tied to ICH E6(R3).
For educators
- How can educators teach GCP with practice, not only slides? Teach GCP the way it is used: give students a realistic trial situation, ask them to decide, show them the consequence, and tie the feedback to the section of ICH E6(R3) that applies.